Identifying New Therapeutic Targets via Modulation of Protein Corona Formation by Engineered Nanoparticles
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
BACKGROUND: We introduce a promising methodology to identify new therapeutic targets in cancer. Proteins bind to nanoparticles to form a protein corona. We modulate this corona by using surface-engineered nanoparticles, and identify protein composition to provide insight into disease development. METHODS/PRINCIPAL FINDINGS: Using a family of structurally homologous nanoparticles we have investigated the changes in the protein corona around surface-functionalized gold nanoparticles (AuNPs) from normal and malignant ovarian cell lysates. Proteomics analysis using mass spectrometry identified hepatoma-derived growth factor (HDGF) that is found exclusively on positively charged AuNPs ((+)AuNPs) after incubation with the lysates. We confirmed expression of HDGF in various ovarian cancer cells and validated binding selectivity to (+)AuNPs by Western blot analysis. Silencing of HDGF by siRNA resulted s inhibition in proliferation of ovarian cancer cells. CONCLUSION: We investigated the modulation of protein corona around surface-functionalized gold nanoparticles as a promising approach to identify new therapeutic targets. The potential of our method for identifying therapeutic targets was demonstrated through silencing of HDGF by siRNA, which inhibited proliferation of ovarian cancer cells. This integrated proteomics, bioinformatics, and nanotechnology strategy demonstrates that protein corona identification can be used to discover novel therapeutic targets in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mass spectrometry-based proteomics
Aebersold, R., & Mann, M. (2003) · Nature · doi:10.1038/nature01511 · Cited by 6,955
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Rifai, N., Gillette, M. A., & Carr, S. A. (2006) · Nature Biotechnology · doi:10.1038/nbt1235 · Cited by 1,867
Monopoli, M. P., Walczyk, D., Campbell, A., Elia, G., Lynch, I., Baldelli Bombelli, F., & Dawson, K. A. (2011) · Journal of the American Chemical Society · doi:10.1021/ja107583h · Cited by 1,835
Immunological properties of engineered nanomaterials
Dobrovolskaia, M. A., & McNeil, S. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.223 · Cited by 1,823 · cited 2×
“To this end, research groups have intently focused on determining the composition of the nanoparticle corona with human plasma [3,7,12,15,31,32], demonstrating that nanoparticle surface size and properties play a critical role in protein adsorption [33–35].”
BackgroundAggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A., & McNeil, S. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.009 · Cited by 1,791 · cited 1×
“To this end, research groups have intently focused on determining the composition of the nanoparticle corona with human plasma [3,7,12,15,31,32], demonstrating that nanoparticle surface size and properties play a critical role in protein adsorption [33–35].”
BackgroundThe influence of protein adsorption on nanoparticle association with cultured endothelial cells
Ehrenberg, M. S., Friedman, A. E., Finkelstein, J. N., Oberdörster, G., & McGrath, J. L. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.09.050 · Cited by 412
Cited by
Yao, J., Yang, M., & Duan, Y. (2014) · Chemical Reviews · doi:10.1021/cr200359p · Cited by 944
Protein corona: a new approach for nanomedicine design
Nguyen, V. H., & Lee, B.-J. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s129300 · Cited by 638
Uptake of Engineered Gold Nanoparticles into Mammalian Cells
Dykman, L. A., & Khlebtsov, N. G. (2014) · Chemical Reviews · doi:10.1021/cr300441a · Cited by 292
Exploiting the Protein Corona around Gold Nanorods for Loading and Triggered Release
Kah, J. C. Y., Chen, J., Zubieta, A., & Hamad-Schifferli, K. (2012) · ACS Nano · doi:10.1021/nn301389c · Cited by 178
Stealth Effect of Biomolecular Corona on Nanoparticle Uptake by Immune Cells
Caracciolo, G., Palchetti, S., Colapicchioni, V., Digiacomo, L., Pozzi, D., Capriotti, A. L., La Barbera, G., & Laganà, A. (2015) · Langmuir · doi:10.1021/acs.langmuir.5b02158 · Cited by 131
Metadata
- Authors
- Arvizo, R. R., Giri, K., Moyano, D., Miranda, O. R., Madden, B., McCormick, D. J., Bhattacharya, R., Rotello, V. M., Kocher, J.-P., & Mukherjee, P.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-03-19
- Volume
- 7
- Issue
- 3
- Pages
- e33650
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2006806281
- Cited by
- 98
- References
- 7
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Identifying New Therapeutic Targets via Modulation of Protein Corona Formation by Engineered Nanoparticles. https://app.cochat.ai/papers/10.1371/journal.pone.0033650
- The paper
- Arvizo, R. R., Giri, K., Moyano, D., Miranda, O. R., Madden, B., McCormick, D. J., Bhattacharya, R., Rotello, V. M., Kocher, J.-P., & Mukherjee, P. (2012). Identifying New Therapeutic Targets via Modulation of Protein Corona Formation by Engineered Nanoparticles. PLoS ONE. https://doi.org/10.1371/journal.pone.0033650
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.